R DOUGLAS NORBY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for R DOUGLAS NORBY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of R DOUGLAS NORBY. R DOUGLAS NORBY is a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in MAGNACHIP SEMICONDUCTOR Corp ($MX) and a Director in Krystal Biotech, Inc. ($KRYS).
Address: C/O ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE 06410 CT
Companies in which R DOUGLAS NORBY is an Insider
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of R DOUGLAS NORBY: Director
Holdings: 4,906 shares
Current Value: $626,594
Latest Transaction: May 12 2017
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Krystal Biotech, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of R DOUGLAS NORBY: Director
Holdings: 9,000 shares
Latest Transaction: Jun 04 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MAGNACHIP SEMICONDUCTOR Corp
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of R DOUGLAS NORBY: Director
Holdings: 22,020 shares
Current Value: $188,271
Latest Transaction: Mar 16 2016
$MX Market Capitalization: $295.73M
$MX Previous Close: $8.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of R DOUGLAS NORBY
Sentiment: All, ALXN, KRYS, MX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2018 | KRYS | Krystal Biotech, I ... | NORBY R DOUGLAS | Director | Option Exercise | A | 10.29 | 7,500 | 77,175 | 7,500 | |
| May 11 2018 | KRYS | Krystal Biotech, I ... | NORBY R DOUGLAS | Director | Buy | P | 10.42 | 9,000 | 93,780 | 9,000 | 0 to 9 K |
| May 12 2017 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 0.00 | 2,030 | 0 | 4,906 | 2.9 K to 4.9 K (+70.58 %) |
| Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 131.97 | 1,774 | 234,115 | 2,876 | 4.7 K to 2.9 K (-38.15 %) |
| Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 131.10 | 3,724 | 488,216 | 4,650 | 8.4 K to 4.7 K (-44.47 %) |
| Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 130.03 | 2,800 | 364,084 | 8,374 | 11.2 K to 8.4 K (-25.06 %) |
| Sep 27 2016 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Sell | M | 128.81 | 7,202 | 927,690 | 11,174 | 18.4 K to 11.2 K (-39.19 %) |